Drug Discovery Solutions
-
Meet MaruXTM: Setting The Standard For End-To-End Continuous Biomanufacturing
5/13/2026
Continuous biomanufacturing boosts speed, flexibility, and control. Modular automation, intensified processing, and streamlined workflows drive productivity and consistent quality.
-
Small Molecules Discovery
5/28/2026
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.
-
Custom Synthesis Services
5/28/2026
For more than 30 years Curia has been meeting the custom synthesis needs of our clients.
-
In Vitro Biology
5/28/2026
Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.
-
CRISPR/Cas9 And Cas9 Variants
9/30/2025
A quick overview of this industry-changing technology as well as the newer Cas9 variants that expand its use.
-
Research And Development Services For Gene Therapies
9/16/2025
Our mission is clear: to help sponsors reduce costs, shorten timelines, and de-risk development, so they can achieve critical milestones, secure investments, and advance life-changing therapies.
-
Antibody Discovery And Engineering
5/28/2026
The Antibody Center at Curia provides end-to-end services in antibody discovery, engineering, and development.
-
Oligonucleotide CDMO: From Preclinical To Commercial
3/11/2026
See how flexible synthesis platforms, structured CMC strategies, and advanced purification tools boost scalability, control impurities, and strengthen readiness for clinical and commercial oligo programs.